AeroLeads people directory · profile

Bo Lang Email & Phone Number

Principal Scientist at Alexion, AstraZeneca Rare Disease at Alexion Pharmaceuticals, Inc.
Location: New Haven, Connecticut, United States 11 work roles 2 schools
1 work email found @bms.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email b****@bms.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Alexion Pharmaceuticals, Inc.
Role
Principal Scientist at Alexion, AstraZeneca Rare Disease
Location
New Haven, Connecticut, United States
Company size
1001 employees

Who is Bo Lang? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Bo Lang is listed as Principal Scientist at Alexion, AstraZeneca Rare Disease at Alexion Pharmaceuticals, Inc., a company with 1001 employees, based in New Haven, Connecticut, United States. AeroLeads shows a work email signal at bms.com and a matched LinkedIn profile for Bo Lang.

Bo Lang previously worked as Principal Scientist at Alexion Pharmaceuticals, Inc. and Senior Principal Scientist, Drug Product Development at Bristol Myers Squibb. Bo Lang holds Ph.D., Pharmaceutics from The University Of Texas At Austin.

Company email context

Email format at Alexion Pharmaceuticals, Inc.

This section adds company-level context without repeating Bo Lang's masked contact details.

{first}.{last}@bms.com
86% confidence

AeroLeads found 1 current-domain work email signal for Bo Lang. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Bo Lang

- Ph.D. in pharmaceutics with 10 years of industry experience; end-to-end experience in oral drug product development from GLP tox to NDA submission; specialized in oral delivery of poorly soluble/permeable compounds with multiple patent applications; effective matrix team leader contributed to the formulation development and biopharmaceutical assessment of 10+ BMS assets; now overseeing the biopharmaceutical aspect of all BMS early-stage hematology assets from GLP tox to clinical PoC- Led the formulation development of BMS’ first clinical stage oral peptide program; successfully demonstrated technical feasibility in multiple pre-clinical animal models and advanced selected formulations into clinical studies; filed multiple patent applications/memo of inventions; received BMS STELA Award- Led the late-stage drug product process development of BMS TYK2 inhibitor (deucravacitinib) program; contributed to the successful NDA submission (SOTYKTU, FDA approved in September 2022)

Listed skills include Formulation, Hplc, Dissolution, Tga, and 22 others.

Current workplace

Bo Lang's current company

Company context helps verify the profile and gives searchers a useful next step.

Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Principal Scientist at Alexion, AstraZeneca Rare Disease
121 Seaport Blvd, Boston, MA 02210, USA
Website
alexion.com
Employees
1001
AeroLeads page
Company profile
View company profile Email format
11 roles

Bo Lang work experience

A career timeline built from the work history available for this profile.

Senior Principal Scientist, Drug Product Development

Bristol Myers Squibb

Lawrence Township, NJ, US

- Leading formulation development and biopharmaceutics assessment of multiple poorly permeable clinical stage compounds at BMS- Leading a cross-functional team to develop formulation platform and performance testing methodology for oral delivery of poorly permeable compounds, including proteolysis targeting chimeras (PROTACs) and conjugated peptides.

Apr 2022 - Jul 2023

Principal Scientist, Drug Product Development

Bristol Myers Squibb

Lawrence Township, NJ, US

- Drug delivery and biopharmaceutical R&D of new modalities (conjugated peptides, PROTACs, etc.)- Received 2022 BMS Science, Technology, and Engineering Leadership Award (STELA award) for developing and implementing a novel formulation approach to achieve program-advancing bioavailability of a poorly permeable compound

Jan 2021 - Apr 2022

Research Investigator Ii, Drug Product Science & Technology

Bristol Myers Squibb

Lawrence Township, NJ, US

Apr 2016 - Sep 2018

Research Investigator I, Drug Product Science & Technology

Bristol Myers Squibb

Lawrence Township, NJ, US

Jun 2015 - Apr 2016

Formulation Scientist, Product Development

Mylan

Canonsburg, Pennsylvania, US

Formulation development and process scale-up of solid oral dosage forms.

Aug 2013 - May 2015

Summer Intern, Formulation And Process Development

Gilead Sciences

Foster City, CA, US

Investigated the strategies to improve the dissolution rate of tablet formulations.

May 2012 - Aug 2012

Graduate Research Assistant

University Of Texas At Austin

Austin, TX, US

  • Investigated the effect of formulation variables (i.e., polymeric carriers, pore-forming agents, and plasticizers) on the drug release profile and physical stability of hot-melt extruded amorphous solid dispersions.
  • Investigated the effect of processing variables (i.e., screw design, processing temperature) on the drug release profile and physical stability of hot-melt extruded amorphous solid dispersions.
  • Developed a high drug loading immediate release tablet formulation comprising hot-melt extruded amorphous solid dispersions.
  • Optimized the dissolution profile of a lyophilized itraconazole amorphous solid dispersion by selecting polymeric carriers and surfactants.
  • Optimized the dissolution profile of a lyophilized itraconazole dry emulsion formulation by selecting polymeric carriers with different chemical properties and viscosities.
  • Completed a variety of side research projects such as dissolution testing, drug layering, film coating, and peptide analysis.
Jan 2009 - Apr 2012

Teaching Assistant

University Of Texas At Austin

Austin, TX, US

Teaching assistant in Compounding Lab and Physical Pharmacy

Jan 2009 - May 2010

Undergraduate Research Assistant

University Of Science And Technology Of China

Hefei, Anhui, CN

  • Investigated the mechanism of breast cancer cells metastasis as an undergraduate research assistant; published the research results in Cancer Letters as a main contributor and co-author.
  • Successfully completed an undergraduate research project and honorably rewarded “Outstanding Undergraduate Research” (Top 5%).
Dec 2006 - Jun 2008
Team & coworkers

Colleagues at Alexion Pharmaceuticals, Inc.

Other employees you can reach at alexion.com. View company contacts for 1001 employees →

VZ Virginijus Zvinklys Virginijus Zvinklys Colleague at Alexion Pharmaceuticals, Inc. Bessbrook, Northern Ireland, United Kingdom, United Kingdom View → TM Tiago Monteiro Tiago Monteiro Colleague at Alexion Pharmaceuticals, Inc. Lisboa, Lisbon, Portugal, Portugal View → MP Michele Peruzzi Michele Peruzzi Colleague at Alexion Pharmaceuticals, Inc. Meriden, Connecticut, United States, United States View → JE Jackie Embry Jackie Embry Colleague at Alexion Pharmaceuticals, Inc. Athens, Georgia, United States, United States View → MH Mohammed Hamada Mohammed Hamada Colleague at Alexion Pharmaceuticals, Inc. Palestinian Authority, Palestine, State Of View → ND Norvin D'Cunha - Pmp, Safe, Grcp, Coupa, Lean Six Sigma Norvin D'Cunha - Pmp, Safe, Grcp, Coupa, Lean Six Sigma Colleague at Alexion Pharmaceuticals, Inc. New Haven, Connecticut, United States, United States View → SM Sierra Mcmonagle, Bs, Rn Sierra Mcmonagle, Bs, Rn Colleague at Alexion Pharmaceuticals, Inc. Downingtown, Pennsylvania, United States, United States View → 永 永田恭史 永田恭史 Colleague at Alexion Pharmaceuticals, Inc. Matsumoto, Nagano, Japan, Japan View → JY Jin Yang Jin Yang Colleague at Alexion Pharmaceuticals, Inc. Cambridge, Massachusetts, United States, United States View → JL Justin L. Burt Justin L. Burt Colleague at Alexion Pharmaceuticals, Inc. New York City Metropolitan Area, United States, United States View →
2 education records

Bo Lang education

Ph.D., Pharmaceutics

The University Of Texas At Austin

Bachelor, Bioscience

University Of Science And Technology Of China
FAQ

Frequently asked questions about Bo Lang

Quick answers generated from the profile data available on this page.

What company does Bo Lang work for?

Bo Lang works for Alexion Pharmaceuticals, Inc..

What is Bo Lang's role at Alexion Pharmaceuticals, Inc.?

Bo Lang is listed as Principal Scientist at Alexion, AstraZeneca Rare Disease at Alexion Pharmaceuticals, Inc..

What is Bo Lang's email address?

AeroLeads has found 1 work email signal at @bms.com for Bo Lang at Alexion Pharmaceuticals, Inc..

Where is Bo Lang based?

Bo Lang is based in New Haven, Connecticut, United States while working with Alexion Pharmaceuticals, Inc..

What companies has Bo Lang worked for?

Bo Lang has worked for Alexion Pharmaceuticals, Inc., Bristol Myers Squibb, Mylan, Gilead Sciences, and University Of Texas At Austin.

Who are Bo Lang's colleagues at Alexion Pharmaceuticals, Inc.?

Bo Lang's colleagues at Alexion Pharmaceuticals, Inc. include Virginijus Zvinklys, Tiago Monteiro, Michele Peruzzi, Jackie Embry, and Mohammed Hamada.

How can I contact Bo Lang?

You can use AeroLeads to view verified contact signals for Bo Lang at Alexion Pharmaceuticals, Inc., including work email, phone, and LinkedIn data when available.

What schools did Bo Lang attend?

Bo Lang holds Ph.D., Pharmaceutics from The University Of Texas At Austin.

What skills is Bo Lang known for?

Bo Lang is listed with skills including Formulation, Hplc, Dissolution, Tga, Characterization, Tableting, Design Of Experiments, and Cell Culture.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.